Home › Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting
 

Keywords :   


Euroscreen To Present ESN364; An Innovative Drug Candidate For The Treatment Of Women's Health Disorders At The ICE/ENDO Meeting

2014-07-02 10:27:34| drugdiscoveryonline Home Page

Euroscreen, a private drug development company, announced today that its ESN364 Phase I clinical candidate, will be presented at the ICE/ENDO Meeting on Sunday, June 22nd (Chicago, IL)

Tags: the health present meeting

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.09Hurricane John Graphics
24.09Summary for Hurricane John (EP5/EP102024)
24.09Hurricane John Public Advisory Number 6A
24.09Potential Tropical Cyclone Nine Public Advisory Number 2A
24.09Summary for Potential Tropical Cyclone Nine (AT4/AL092024)
24.09CrowdStrike: Company to face questions over global IT outage
24.09Tigers and crocs make mangrove preservation tough work
24.09Atlantic Tropical Weather Outlook
More »